http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113286798-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-36 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113286798-B |
| titleOfInvention | Endocyclic thiamidine amide-aryl amide compound and its use in treating hepatitis B |
| abstract | The present invention relates to an inner ring thiamidine amide-aryl amide compound and its application for treating hepatitis B. Specifically, the present invention discloses a compound that can be used as an HBV replication inhibitor, the compound having the structure shown in chemical formula (A) or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt thereof, hydrated Compound or solvate, the definition of each group is detailed in the description. The present invention also relates to pharmaceutical compositions comprising the above-mentioned compounds and their use in the treatment of hepatitis B. |
| priorityDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.